top of page
Categories
Pharmacovigilance and Post-Marketing Surveillance
Adverse event reporting systems (FAERS, VAERS)
Benefit–risk assessment frameworks
Drug safety monitoring
Risk evaluation and mitigation strategies (REMS)
Signal detection and disproportionality analysis
Phase IV trials
bottom of page